Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Prognostic value of RASSF1 promoter methylation in prostate cancer.

Daniunaite K, Jarmalaite S, Kalinauskaite N, Petroska D, Laurinavicius A, Lazutka JR, Jankevicius F.

J Urol. 2014 Jun 26. pii: S0022-5347(14)03913-5. doi: 10.1016/j.juro.2014.06.075. [Epub ahead of print]

PMID:
24980613
[PubMed - as supplied by publisher]
2.

High-resolution melting-based quantitative analysis of RASSF1 methylation in breast cancer.

Stuopelytė K, Daniūnaitė K, Laurinavičienė A, Ostapenko V, Jarmalaitė S.

Medicina (Kaunas). 2013;49(2):78-83.

PMID:
23888343
[PubMed - indexed for MEDLINE]
Free Article
3.

Epigenetic markers of prostate cancer in plasma circulating DNA.

Cortese R, Kwan A, Lalonde E, Bryzgunova O, Bondar A, Wu Y, Gordevicius J, Park M, Oh G, Kaminsky Z, Tverkuviene J, Laurinavicius A, Jankevicius F, Sendorek DH, Haider S, Wang SC, Jarmalaite S, Laktionov P, Boutros PC, Petronis A.

Hum Mol Genet. 2012 Aug 15;21(16):3619-31. doi: 10.1093/hmg/dds192. Epub 2012 May 22.

PMID:
22619380
[PubMed - indexed for MEDLINE]
Free Article
4.

Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer.

Sabaliauskaite R, Jarmalaite S, Petroska D, Dasevicius D, Laurinavicius A, Jankevicius F, Lazutka JR.

Genes Chromosomes Cancer. 2012 Aug;51(8):781-91. doi: 10.1002/gcc.21963. Epub 2012 Apr 16.

PMID:
22505341
[PubMed - indexed for MEDLINE]
5.

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.

Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J.

Diagn Pathol. 2012 Mar 16;7:27. doi: 10.1186/1746-1596-7-27.

PMID:
22424533
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure.

Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K.

Mutagenesis. 2012 Jul;27(4):423-9. doi: 10.1093/mutage/ger092. Epub 2012 Jan 4.

PMID:
22217548
[PubMed - indexed for MEDLINE]
Free Article
7.

Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.

Laurinaviciene A, Dasevicius D, Ostapenko V, Jarmalaite S, Lazutka J, Laurinavicius A.

Diagn Pathol. 2011 Sep 23;6:87. doi: 10.1186/1746-1596-6-87.

PMID:
21943197
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.

Jarmalaite S, Laurinaviciene A, Tverkuviene J, Kalinauskaite N, Petroska D, Böhling T, Husgafvel-Pursiainen K.

Cancer Genet. 2011 Jul;204(7):398-404. doi: 10.1016/j.cancergen.2011.07.002.

PMID:
21872827
[PubMed - indexed for MEDLINE]
9.

Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.

Daniūnaitė K, Berezniakovas A, Jankevičius F, Laurinavičius A, Lazutka JR, Jarmalaitė S.

Medicina (Kaunas). 2011;47(3):147-53. English, Lithuanian.

PMID:
21822036
[PubMed - indexed for MEDLINE]
Free Article
10.

Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study.

Jarmalaite S, Andrekute R, Scesnaite A, Suziedelis K, Husgafvel-Pursiainen K, Jankevicius F.

J Cancer Res Clin Oncol. 2010 Jun;136(6):847-54. doi: 10.1007/s00432-009-0725-y. Epub 2009 Nov 19.

PMID:
19924441
[PubMed - indexed for MEDLINE]
11.

Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.

Jarmalaite S, Jankevicius F, Kurgonaite K, Suziedelis K, Mutanen P, Husgafvel-Pursiainen K.

Oncology. 2008;75(3-4):145-51. doi: 10.1159/000158665. Epub 2008 Sep 29.

PMID:
18824877
[PubMed - indexed for MEDLINE]
12.

Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.

Lemeta S, Jarmalaite S, Pylkkänen L, Böhling T, Husgafvel-Pursiainen K.

J Neuropathol Exp Neurol. 2007 Sep;66(9):860-7.

PMID:
17805016
[PubMed - indexed for MEDLINE]
13.

Sister chromatid exchanges and cell proliferative abilities in cultured peripheral blood lymphocytes of patients with rheumatoid and reactive arthritis.

Jarmalaite S, Mierauskiene J, Beitas K, Ranceva J, Lazutka JR, Butrimiene I.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6):677-82.

PMID:
17207384
[PubMed - indexed for MEDLINE]
14.

CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.

Wikman H, Nymark P, Väyrynen A, Jarmalaite S, Kallioniemi A, Salmenkivi K, Vainio-Siukola K, Husgafvel-Pursiainen K, Knuutila S, Wolf M, Anttila S.

Genes Chromosomes Cancer. 2005 Feb;42(2):193-9.

PMID:
15543620
[PubMed - indexed for MEDLINE]
15.

Different cytokine profiles in patients with chronic and acute reactive arthritis.

Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene A.

Rheumatology (Oxford). 2004 Oct;43(10):1300-4. Epub 2004 Jul 20.

PMID:
15266062
[PubMed - indexed for MEDLINE]
Free Article
16.

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K.

Int J Cancer. 2003 Oct 10;106(6):913-8.

PMID:
12918069
[PubMed - indexed for MEDLINE]
17.

Modifying effects of interferon and puromycin on cytogenetic damage induced by alkylating drug phopurine in human lymphocytes.

Lazutka JR, Jarmalaitè S, Lekevicius R.

Acta Biol Hung. 1990;41(1-3):137-48.

PMID:
1709768
[PubMed - indexed for MEDLINE]
18.

In vitro interaction between two antineoplastic drugs--phopurinum and interferon alpha 2.

Lazutka JR, Slapsyte G, Jarmalaite S, Lekevicius RK.

Cancer Lett. 1989 Sep 15;47(1-2):53-6.

PMID:
2636032
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk